Cell Counting Kit-8 (CCK-8) |
Catalog No.GK10001 |
Cell Counting Kit-8 (CCK-8) es una solución lista para usar en un solo frasco, que ofrece una medición simple, rápida, confiable y sensible de la viabilidad celular y la citotoxicidad de varios productos químicos.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2024):2401538.PMID:38738793
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Nat Commun 15.1 (2024):3771.PMID:38704377
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Matter (2025).
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Commun (2024).PMID:38512764
- ACS nano (2025).PMID:39846120
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Acs Nano (2024).PMID:39361472
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Brain Behav Immun (2024).PMID:38565398
- Adv Sci (2023):2301107.PMID:37097746
- Adv Sci (2024):2401845.PMID:38757623
- Autophagy just-accepted (2024).PMID:39007910
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2024):2404365.PMID:39159143
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2025):2413936.PMID:40047320
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Adv Res (2023).PMID:36933884
- Nano Today 61 (2025):102560.
- Small (2024):2407674.PMID:39363789
- Water Res (2024):121379.PMID:38422694
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Small 21.3 (2025):2409121.PMID:39544127
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Mol Ther (2025).PMID:39810420
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Small Methods (2024):2400223.PMID:38602202
- Theranostics 12.7 (2022):3488.PMID:35547749
- Theranostics 14.16 (2024):6161.PMID:39431016
- J Hazard Mater (2024):135904.PMID:39303616
- Mater Horiz (2024).PMID:39189308
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Mater Horiz (2024).PMID:39189308
- Water Res (2024):122403.PMID:39278116
- J Control Release 373 (2024):749-765.PMID:39084465
- Cell Discov 6.1 (2020):96.PMID:33349633
- Environ Sci Technol (2024).PMID:39364562
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Control Release 349 (2022):254-268.PMID:35803328
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- Redox Biol 62 (2023):102663.PMID:36924682
- J Adv Res (2025).
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Control Release 359 (2023):12-25.PMID:37244298
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Control Release 360 (2023):647-659.PMID:37406817
- J Control Release 365 (2024):301-316.PMID:38007195
- EBioMedicine 99 (2024).PMID:38101299
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- Acta Biomater 157 (2023):321-336.PMID:36481504
- Redox Biol (2023):102983.PMID:38064762
- Sci Total Environ 878 (2023):162942.PMID:36940749
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Cancer Lett (2024):216765.PMID:38408604
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Acta Biomater (2024).PMID:38452962
- Biomark Res 11.1 (2023):3PMID:36611218
- Environ Pollut 338 (2023):122581.PMID:37748638
- Pharmacol Res (2024):107460.PMID:39393436
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Liver Int 43.4 (2023):840-854.PMID:36737842
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Food Chem (2024):139505.PMID:38703732
- Front Immunol 14 (2023):1130308.PMID:37006248
- Brit J Cancer (2024):1-9.PMID:38594370
- Acs Appl Mater Inter (2024).PMID:38345297
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Environ Pollut 334 (2023):122148.PMID:37419204
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Pharmacol Res 180 (2022):106225.PMID:35452801
- J Colloid Interf Sci (2025):.PMID:39755016
- Acta Biomater (2025).PMID:40024424
- Acta Biomater (2025).PMID:39952883
- Cancer Lett 611 (2025):217418.PMID:39725146
- Cancer Lett (2024):217418.PMID:39725146
- Acs Appl Mater Inter 15.32 (2023):38294-38308.PMID:37542453
- Phytomedicine 118 (2023):154944.PMID:37393830
- Phytomedicine 122 (2024):155091.PMID:37844378
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Int J Biol Macromol (2025):141146.PMID:39986528
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Acs Appl Mater Inter (2025).PMID:39853325
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Int J Biol Macromol(2023):125130.PMID:37263336
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2024):133667.PMID:38969038
- Mater Today Bio (2024):101019.PMID:38516170
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol (2024):131928.PMID:38688339
- Int J Biol Sci 21.4 (2025):1837-1851.
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Sci China Life Sci (2025):1-11.PMID:39821161
- Acs Appl Mater Inter (2024).PMID:39448903
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Int J Biol Macromol (2025):140374.PMID:39880265
- Acs Sensors (2024).PMID:38958530
- Int J Biol Macromol (2025):140632.PMID:39909240
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Antivir Res 205 (2022):105381.PMID:35835291
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Int J Biol Macromol (2025):141767.
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Int J Biol Macromol (2024):135979.PMID:39332550
- Int J Biol Macromol (2025):140602.PMID:39922352
- Acs Appl Mater Inter (2024).PMID:39320506
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Macromol (2024):135562.PMID:39276884
- Nanoscale Horiz (2025).
- Int J Biol Macromol (2024):129172.PMID:38176496
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Acs Appl Mater Inter (2025).PMID:40025657
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Phytomedicine (2023):155270.PMID:38096717
- Int J Biol Macromol (2024):137561.PMID:39537068
- Environ Res (2024):118221.PMID:38246300
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Life Sci 308 (2022):120925.PMID:36057399
- J Med Chem (2025).PMID:39842821
- Brit J Pharmacol (2024).PMID:38715438
- Int J Nanomed 20 (2025):293-308.
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Virol Sin (2023).PMID:37331658
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Phytother Res (2024).PMID:38558449
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- J Gastroenterol (2023):1-14.PMID:37150773
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- J Med Chem (2024).PMID:38315032
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Oncogene (2025):1-15.PMID:39920289
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Free Radical Bio Med (2024).PMID:38367927
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Front Nutr 9 (2022):812623.PMID:35419394
- Food Res Int (2025):115940.
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Life Sci 312 (2023):121092.PMID:36279968
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- J Med Chem (2024).PMID:39292661
- Phytomedicine (2024):155859.PMID:38972239
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Phytomedicine (2025):156515.PMID:39983438
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Fertil Steril (2023).PMID:37178109
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Front Immunol 13 (2022):902515.PMID:35874682
- Front Immunol 14 (2023):1111494.PMID:36817451
- Front Immunol 13 (2022):986214.PMID:36341437
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Cell Rep 44.3 (2025).PMID:39977268
- J Med Virol 97.3 (2025):e70267.
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Phytomedicine 130 (2024):155744.PMID:38763011
- Phytomedicine (2025):156598.
- Front Immunol 14 (2023).PMID:37662906
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Front Oncol 12 (2022):858598.PMID:35321435
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Front Oncol 13 (2023):1120103.PMID:36959804
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Microbiol Res (2024):127927.PMID:39393129
- Life Sci (2024):122483.PMID:38307238
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Jci insight 9.15 (2024):PMID:38935435
- Mol Med 30 (2024):260.PMID:39707194
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Mbio (2023):e01688-23.PMID:37882780
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- J Mater Chem B (2024).PMID:39119756
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Acs Biomater Sci Eng (2024).PMID:38445959
- J Transl Med 23.1 (2025):131.PMID:39885513
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Front Immunol 15 (2024):1375781.PMID:39391314
- Biochem Pharmacol (2024):116044.PMID:38336157
- Front Pharmacol 11 (2020):16.PMID:32140106
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Exp Neurol 359 (2023):114266.PMID:36336032
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- J Agr Food Chem (2025).PMID:40017402
- Mol Med 30.1 (2024):14.PMID:38254010
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Phytother Res (2023).PMID:37086359
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Mol Cell Proteomics (2025):100930.PMID:40024376
- Biomater Adv (2024):214069.PMID:39447240
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Acs Biomater Sci Eng (2024).PMID:38446137
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Biomater Adv (2025):214257.PMID:40023084
- Int J Pharmaceut (2023):123142.PMID:37328119
- Cns Neurosci Ther (2023).PMID:37452510
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Colloid Surface B 222 (2023):113119.PMID:36621177
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- J Agr Food Chem (2023).PMID:37922022
- Front Immunol 15 (2024):1455996.PMID:39376562
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Cells 11.23 (2022):3816.PMID:36497076
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Oncol 12 (2022):858598.PMID:35321435
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Resp Res 24.1 (2023):216.PMID:37674165
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Int J Mol Med 55.3 (2025):1-17.
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Lab Chip (2024).PMID:38939907
- Jci Insight (2024). PMID:38935435
- Talanta (2025):127591.PMID:39847915
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- J Nutr Biochem (2024):109678.PMID:38844080
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- J Invest Dermatol (2025).PMID:39892773
- Biochem Pharmacol (2023):115632.PMID:37263300
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- J Agr Food Chem (2025).PMID:39962827
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Front Oncol 12 (2022):770628.PMID:35372056
- Am J Chinese Med (2024):1-23.PMID:38490807
- Phytother Res (2023).PMID:37246830
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Front Oncol 13 (2023):1132424.PMID:37251940
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Cells 11.24 (2022):4094.PMID:36552856
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Front Immunol 15 (2024):1455996.PMID:39376562
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Apoptosis (2024):1-19.PMID:39097858
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- J Virol (2023):e00549-23.PMID:37222617
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Front Oncol 12 (2022):1043161.PMID:36439418
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Molecules 28.6 (2023):2426.PMID:36985397
- J Oncol 2022 (2022):6459029PMID:36199788
- Bioorg Chem 136 (2023):106556.PMID:37105002
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Front Oncol 12 (2022):996080.PMID:36483054
- Front Oncol 12 (2022):961653.PMID:36457504
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- J Oncol 2022 (2022).PMID:36281290
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- J Ethnopharmacol (2023):116731.PMID:37277084
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Molecules 27.17 (2022):5698.PMID:36080465
- Cell Signal 113 (2024):110962.PMID:37931691
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- J Oncol 2022 (2022).PMID:36213838
- Mol Carcinogen (2023).PMID:37750597
- Bioengineering 9.9 (2022):433.PMID:36134979
- Molecules 27.14 (2022):4603.PMID:35889477
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Molecules 27.21 (2022):7183.PMID:36364008
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Cell Signal (2023):110987.PMID:38029946
- Molecules 27.23 (2022):8568.PMID:36500666
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Acs Biomater Sci Eng (2024).PMID:39164198
- J Ethnopharmacol (2024):118685.PMID:39127116
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Biochem Pharmacol (2024):116438.PMID:39025409
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Mol Neurobiol (2024):1-18.PMID:38995443
- Clin Immunol (2024):110308.PMID:39002794
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Arch Toxicol (2024):1-16.PMID:38971901
- Environ Toxicol (2023).PMID:38069587
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Macromol Biosci (2024):2400003.PMID:38597147
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Life Sci 254 (2020):117793.PMID:32416164
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- J Dent (2024):105436.PMID:39488296
- J Ethnopharmacol (2024):119272.PMID:39716512
- Radiother Oncol (2024):110686.PMID:39709027
- Transl Oncol 52 (2025):102256.PMID:39733744
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Glia (2024).PMID:39610064
- Biochem Pharmacol (2024):116688.PMID:39617210
- Toxicology (2024):154018.PMID:39608440
- J Ethnopharmacol (2024):119073.PMID:39522846
- Colloid Surface B (2025):114537.PMID:39879672
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- J Dent (2024):105436.PMID:39488296
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- J Agr Food Res (2025):101694.
- J Drug Deliv Sci Tec 104 (2025) 106577.
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Commun Biol 8.1 (2025):71.PMID:39820362
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Life Sci (2024):123148.PMID:39447733
- Nutrients 17.5 (2025):923.PMID:40077793
- J Nutr Biochem (2024):109780.PMID:39395694
- Am J Physiol-Gastr L (2024).PMID:38742280
- Transl Oncol 47 (2024):102042.PMID:38924847
- J Ethnopharmacol (2024):117958.PMID:38395179
- J oncol 2022 (2022).PMID:36385962
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Ethnopharmacol (2024):118080.PMID:38521426
- J Oncol 2022 (2022).PMID:36213831
- Faseb J 38.7 (2024):e23591.PMID:38572579
- J Ethnopharmacol (2024):117985.PMID:38417600
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Macromol Biosci (2024):2400003.PMID:38597147
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Environ Toxico (2024).PMID:38700384
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Acs Appl Bio Mater (2024).PMID:38700956
- J Ethnopharmacol (2024):117865.PMID:38369066
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Zool Res 45.5 (2024):1001.PMID:39147715
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Endocrine (2024):1-14.PMID:38378893
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Front Oncol 14 (2024):1440906.PMID:39346724
- Endocrine (2024).PMID:38191984
- J Steroid Biochem (2023):106429.PMID:38035949
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Cytokine 176 (2024):156507.PMID:38244240
- Environ Toxicol (2024).PMID:39400944
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- Front Oncol 14 (2024):1471109.PMID:39582546
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Gerontology (2024).PMID:38168028
- Oral Dis (2024).PMID:38168877
- Brain Res Bull (2024):111165.PMID:39667505
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Zool Res 45.5 (2024).PMID:39147715
- Heliyon (2024).PMID:38707472
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Gene (2024):148399.PMID:38518902
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- J Biol Chem (2024):107499.PMID:38944125
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- J Immunother (2024):10-1097.PMID:38847148
- Toxicol Sci (2024):kfae054.PMID:38636494
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Bmc Complement Med 24 (2024).PMID:38783288
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- J Cancer 15.5 (2024):1397.PMID:38356722
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Metabolomics 20.5 (2024):112.PMID:39369160
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Pediatr Res (2024):1-10.PMID:38658662
- Eur J Pharmacol (2024):176995.PMID:39277096
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Gene (2023):148050.PMID:38042211
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Neurochem Res (2023):PMID:37127800
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Eur J Pharmacol (2025):177343.PMID:39900330
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- J Oncol 2022 (2022).PMID:35518787
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Molecules 30.3 (2025):549.PMID:39942654
- Ann Transl Med 10.24 (2022).PMID:36660714
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Eur J Pharmacol (2025):177497.PMID:40058753
- J Cancer 11.5 (2020):1162.PMID:31956362
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Environ Toxicol (2023).PMID:37052456
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Neuroscience (2023).PMID:37286157
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Sci Rep-Uk 15.1 (2025):794.
- Front Genet 13 (2022):959109.PMID:36147489
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Front Genet 13 (2022):932973.PMID:36118847
- Brain Res Bull (2025):111245.PMID:39924054
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- J Neuro Oncol (2023):1-16.PMID:37351767
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Heliyon 8.11 (2022).PMID:36353164
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Toxicon (2025):108293.PMID:39999927
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Dis Markers 2022 (2022).PMID:35845132
- Int J Chronic Obstr (2025):623-639.
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Cell Transplant 33 (2024).PMID:38334047
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- J Mech Behav Biomed (2025):106963.
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Luminescence 39.1 (2024):e4671.PMID:38286599
- J Sci Food Agr (2024).PMID:39394871
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Tissue Cell (2024):102477.PMID:39018712
- Dis Markers 2022 (2022).PMID:35968506
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Mol Biotechnol (2024):1-15.PMID:38771419
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Future Microbiol 0 (2024).PMID:38629914
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- J Mol Histol (2024):1-8.PMID:38758519
- Virus Res 313 (2022):198748.PMID:35304133
- Gene 932 (2025):148898.PMID:39209182
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Biomarkers (2024):1-12.PMID:38568742
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Technol Cancer Res T 19 (2020).PMID:33111613
- Dis Markers 2022 (2022).PMID:35845132
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Pathogens 14.2 (2025):182.
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Genomics (2025):111009.PMID:39864635
- Shock (2023):10-1097.PMID:37988072
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Planta Med 89.05 (2023):493-507.PMID:35716667
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Shock (2023):10-1097.PMID:37179246
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Clinics 77 (2022).PMID:35662010
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Shock 59.3 (2023):426-433.PMID:36609531
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Heliyon (2024):.PMID:37461802
- S Afr J Bot 177 (2025):445-456.
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Pathogens 14.2 (2025):182.
- Mol Med Rep 31.3 (2025):1-10.
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Tissue Cell 80 (2023):102001.PMID:36565506
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Microb Pathogenesis (2024):107055.PMID:39442820
- Balk Med J 41.6 (2024).PMID:39319820
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Anim Biotechnol (2023):1-12.PMID:36756956
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Hematology 28.1 (2023):2220522.PMID:37272581
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Cell J 24.1 (2022):15.PMID:35182060
- World J Oncol (2024):.
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- J Int Med Res 48.4 (2020).PMID:31891283
- Genes Genom (2023):1-15.PMID:37318704
- Balk Med J 41.6 (2024):491.PMID:39319820
- J Obstet Gynaecol Re PMID:39169658
- J Int Med Res 49.3 (2021).PMID:33730930
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Cell J 24.1 (2022):15.PMID:35182060
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Cell J 25.8 (2023):554.PMID:37641417
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Vet Parasitol (2024):110284.PMID:39126893
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Comb Chem High T Scr (2024).PMID:35894460
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Fitoterapia (2024):106245.PMID:39393711
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Immunobiology (2024):152832.PMID:38943814
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- J Obstet Gynaecol Re PMID:39169658
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Oncol Res 33.1 (2024):103.PMID:39735676
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Chin J Integr Med (2024):1-11.PMID:38941045
- Biochem Genet (2023):1-18.PMID:37148331
- J Int Med Res 48.4 (2020).PMID:31891283
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Neuroreport 33.10 (2022):413.PMID:35623086
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Iran J Immunol (2023).PMID:37865874
- Transl Cancer Res 13.4 (2024).PMID:38737693
- Transpl P 52.1 (2020):398-405.PMID:31928781
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- hLife (2024).
- J Inflamm Res 14 (2021):2445.
- Bioact Mater 44 (2025):220-235.
- Int J Mol Sci 25.15 (2024):8340.
- Nutrients 16.14 (2024):2314.
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- HemaSphere 5.7 (2021).PMID:34136753
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Food Hydrocolloid 120 (2021):106980.
- J Clean Prod 315 (2021):128201.
- Nutrients 16.14 (2024):2346.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- J Funct Foods 123 (2024):106621.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- J Tradit Compl Med (2024).
- Toxins 16.7 (2024):319.
- Drug Resist Update (2024):101161.
- Indian J Pharm Sci 86.3 (2024).
- Front Pharmacol 15:1453938.
- Heliyon (2024).
- Carbohyd Polym (2024):122897.
- Drug Des Dev Ther (2024):5841-5851.
- Int J Mol Sci 25.20 (2024):11184.
- Acs Omega (2024).
- Faseb J 38.15 (2024):e23876.
- Rev Bras Farmacogn (2024):1-7.
- Biosens Bioelectron (2024):116875.
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Viruses 16.8 (2024):1239.
- J Pharm Anal (2024):101053.
- Mol Ther Nucl Acids (2020).
- Heliyon (2024).
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- New J Chem 48.11 (2024):5068-5073.
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Nutr Biochem (2024):109769.PMID:9276944
- bioRxiv (2025):2025-01.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Mater Express 10.1 (2020):102-111.
- Mol Ther-Nucl Acids (2020).
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Ecotox Environ Safe 286 (2024):117233.
- J Transl Med 22.1 (2024):1-16.
- Bioact Mater 43 (2025):32-47.
- Phytomedicine (2024):156091.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Front Oncol 10 (2020):387.
- Int J Mol Sci 25.19 (2024):10339.
- Int J Mol Sci 25.19 (2024):10496.
- Gene (2024) 149056.
- Pharmaceuticals-Base 17.10 (2024):1295.
- Phytother Res 34.4 (2020):836-845.
- Chem Eng J (2024):156542.
- J Hazard Mater (2024):136113.
- bioRxiv (2024) 2024-10.
- Biomedicines 12.11 (2024):2543.
- Small (2024):2402308.PMID:3911
- Mater Res Express 7.2 (2020):025401.
- Acs Appl Mater Inter (2024).PMID:39167710
- Heliyon (2024).
- Phytomedicine 86 (2021):153565.PMID:33945919
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Bioorg Chem (2024):107731.
- Biomaterials 272 (2021):120757.PMID:33798960
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- J Biol Chem 297.2 (2021).PMID:33722608
- scienceasia (2024).
- Biomed Pharmacother 179 (2024):117370.
- J Integr Med-Jim (2024).
- J Transl Med 22.1 (2024) 1-16.
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Acs Appl Nano Mater (2024).
- Front Bioeng Biotech 12 (2024):1460870.
- J Hazard Mater (2024) 135735.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Antioxidants 13.11 (2024) 1320.
- Front Pharmacol 15 (2024):1384141@0.jpg
- Antioxidants-Basel 13.11 (2024):1289.
- Adv Funct Mater 29.50 (2019):1906690.
- Appl Entomol Zool (2022):1-14.
- Appl Entomol Zool 58.4 (2023):303-313.
- Int J Bioprinting (2024).
- Int J Pept Res Ther 29.2 (2023):19.
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Aquaculture 564 (2023):739060.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Adv Funct Mater (2024):2305827.
- Sensor Actuat B-Chem 381 (2023):133437.
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Mol Med 29.1 (2023):6.PMID:36647009
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- Sensors & Diagnostics (2024).
- Adv Funct Mater (2023):2309690.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- J Inflamm Res (2023):1045-1057.PMID:36936349
- Int J Gen Med (2023):5817-5839.PMID:38106976
- View-China 4.2 (2023):20220052.
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Phytomedicine (2024):155347.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- bioRxiv (2023):2023-05.PMID:37292976
- Cancers 14.21 (2022):5218.PMID:36358640
- Molecules 27.16 (2022):5337.PMID:36014573
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Cancers 14.19 (2022):4645.PMID:36230568
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1347683.PMID:38343537
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Mater Today Chem 27 (2023):101331.
- Cells 11.22 (2022):3580.PMID:36429010
- Mol Cell Toxicol (2022):1-11.
- bioRxiv (2024):2024-02.
- Mater Today Bio (2024):100958.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Int J Mol Sci 25.2 (2024):919.
- Food Sci Nutr (2023).
- Biocell 47.8 (2023).
- J Oncol 2022 (2022).PMID:36059813
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Int J Nanomed (2023):5423-5440.PMID:37767196
- bioRxiv (2022):2022-04.
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Chem Eng J 474 (2023):145358.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Front Mar Sci 9 (2022):861117.
- Nanophotonics 11.22 (2022):5089-5100.
- Biocell 47.8 (2023).
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Front Microbiol 14 (2023).PMID:37645224
- Iscience 26.9 (2023).PMID:37670789
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Crystals 13.7 (2023):1067.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Ann Hematol (2023):1-12.
- Biochip J (2023):1-10.
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Crit Rev Eukar Gene 34 (2024).
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Front Immunol 14 (2023).PMID:37901236
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Ceram Int 49.15 (2023):25953-25963.
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Oncol Lett 26.1 (2023):1-17.
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Cell Toxicol (2023):1-10.
- Adv Funct Mater (2023):2214998.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Kaohsiung J Med Sci (2024).PMID:38340032
- New J Chem (2024).
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Front Pharmacol 15 (2024):1389976.
- Pharmaceutics 16.6 (2024):744.
- Tissue Cell 74 (2022):101680.PMID:34808429
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- Nano Today 41 (2021):101326.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Theranostics 14.7 (2024):2687.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Available at SSRN 4830418.
- Heliyon (2024).
- Bio-Des Manuf 5.2 (2022):358-370.
- Phytomedicine (2024):155744.
- Phytochem Lett 47 (2022):174-179.
- bioRxiv (2024):2024-05.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- PeerJ 9 (2021):e11482.PMID:34820154
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Fiber Polym (2022):1-9.
- Am J Cancer Res (2024):2852-2867.
- Biomed Res Int 2021 (2021).PMID:34373837
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Cells 10.9 (2021):2399.PMID:34572049
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Nano Res (2022):1-8.
- Phytochem Lett 46 (2021):79-89.
- Chin Herb Med (2024).
- Acs Omega (2024).
- Talanta (2024):126381.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Mol Cell Biochem (2024) 1-13.
- J Cancer 15.13 (2024):4244-4258.
- Tissue Cell 76 (2022).PMID:35182988
- Nano Today 43 (2022):101416.
- Antioxidants Basel 13.3 (2024):264.
- Phytomedicine 105 (2022):154330.PMID:35905566
- Phytomedicine 103 (2022):154199.PMID:35679793
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Foods 11.11 (2022):1575.PMID:35681325
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Mater Today Adv 15 (2022):100271.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Mater Design (2024):112812.
- Acta Trop 232 (2022):106519.PMID:35584779
- J Oncol 2022 (2022).PMID:35909906
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- J Funct Foods 114 (2024):106076.
- Dis Markers 2022 (2022).
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Front Immunol 15 (2024):1326137.
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Viruses 14.8 (2022):1783.PMID:36016405
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Exp Ther Med 27.5 (2024):1-16.
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Heliyon (2024).
- Front Oncol 12 (2022):851300.PMID:35392243
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Acs Pharmacol Transl (2024).
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Clin Transl Disc 2.2 (2022):e49.
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Int J Mol Sci 25.24 (2024):13439.
Cell Counting Kit-8 (CCK-8) es una solución lista para usar en un solo frasco, que ofrece una medición simple, rápida, confiable y sensible de la viabilidad celular y la citotoxicidad de varios productos químicos. Cell Counting Kit-8 (CCK-8) permite ensayos convenientes utilizando WST-8 (2-(2-metoxi-4-nitrofenil)-3-(4-nitrofenil)-5-(2,4-disulfofenil)-2H-tetrazolio, sal monosódica), que produce un colorante formazán soluble en agua tras la bioreducción en presencia de un portador de electrones, 1-Metoxi PMS. La solución de CCK-8 se añade directamente a las células, sin necesidad de premezcla de componentes. WST-8 es bioreducido por deshidrogenasas celulares a un producto de formazán naranja que es soluble en el medio de cultivo tisular. La cantidad de formazán producido es directamente proporcional al número de células vivas. Dado que la solución de CCK-8 es muy estable y tiene poca citotoxicidad, es posible una incubación más prolongada, como de 24 a 48 horas.
Cell Counting Kit-8 permite ensayos colorimétricos sensibles para la determinación del número de células viables en los ensayos de proliferación y citotoxicidad. La sensibilidad de detección es mayor que la de otras sales de tetrazolio, como MTT, XTT o MTS.
Figura 1: Mecanismos de funcionamiento de Cell Counting Kit-8 (CCK-8).
Determinación del Número de Células
1. Inocular la suspensión celular (100 μL/pozo) en una placa de 96 pozos. Preincubar la placa en un incubador humidificado (por ejemplo, a 37°C, 5% CO2).
2. Añadir 10 μL de solución CCK8 a cada pozo de la placa. Tener cuidado de no introducir burbujas en los pozos, ya que interfieren con la lectura de O.D.
3. Incubar la placa durante 1 a 4 horas en el incubador.
4. Medir la absorbancia a 450 nm utilizando un lector de microplacas.
Ensayo de Proliferación Celular y Citotoxicidad
1. Sembrar las células en una placa de 96 pozos a una densidad de 10^3-10^4 células/pozo en 100 μL de medio de cultivo a probar. Cultivar las células en un incubador de CO2 a 37°C durante 24 horas.
2. Añadir diversas concentraciones de las sustancias a probar a la placa.
3. Incubar la placa durante un tiempo apropiado (por ejemplo, 6, 12, 24 o 48 horas) en el incubador.
4. Añadir 10 μL de solución CCK8 a cada pozo de la placa utilizando un pipeteador repetidor. Tener cuidado de no introducir burbujas en los pozos, ya que interfieren con la lectura de O.D.
5. Incubar la placa durante 1 a 4 horas en el incubador.
6. Antes de leer la placa, es importante mezclar suavemente en un agitador orbital durante 1 minuto para asegurar una distribución homogénea del color.
7. Medir la absorbancia a 450 nm utilizando un lector de microplacas.
Análisis de Datos
Existen varias maneras de realizar el análisis estadístico. Se puede elegir utilizar valores de O.D. o números de células. Ofrecemos una de ellas.
Viabilidad celular (%) = [(As-Ab) / (Ac-Ab)] × 100
Tasa de inhibición (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbancia del pozo experimental (absorbancia de células, medio, CCK8 y pozos del compuesto de prueba).
Ab = absorbancia del pozo en blanco (absorbancia de pozos que contienen medio y CCK8).
Ac = absorbancia del pozo de control (absorbancia de pozos que contienen células, medio y CCK8).
Elaboración de una Curva Estándar
1. La placa de conteo de células cuenta el número de células en la suspensión celular.
2. Utilizando el medio, la suspensión celular se diluye a una gradiente de concentración, generalmente requiriendo de 5 a 7 gradientes de concentración, varios pozos replicados por grupo. Luego se inoculan las células. (Nota el número de células por pozo. Si se diluye la suspensión celular en un tubo, mezclar cuidadosamente las células nuevamente antes de agregar los pozos a la placa. El volumen de la suspensión celular en cada pozo debe ser el mismo).
3. Incubar hasta que las células estén adheridas (generalmente 2-4 horas), luego añadir 10 μL de CCK8 por 100 μL de medio. Continuar la incubación durante 1-4 horas y medir la absorbancia a 450 nm con un lector de microplacas. Elaborar una curva estándar con el número de células como coordenada del eje X y el valor de O.D. como coordenada del eje Y.
El número de células de la muestra a probar se puede determinar con base en la curva. Un requisito previo para utilizar esta curva estándar es que las condiciones de cultivo sean las mismas.
Precauciones
1. Asegurarse de que el fármaco y el CCK8 estén distribuidos uniformemente en el medio.
2. Cuantas más células proliferen, más oscuro será el color; cuanto mayor sea la citotoxicidad, más claro será el color.
3. Para las células adherentes, se requieren al menos 1000 células por pozo (100 μL de medio). Para los leucocitos, se requieren al menos 2500 células por pozo (100 μL de medio) debido a su baja sensibilidad. La placa de 96 pozos recomendada tiene un recuento máximo de células de 25,000 por pozo. Si la prueba se realiza utilizando una placa de 24 pozos o de 6 pozos, calcular el número correspondiente de células por pozo y ajustar el volumen de CCK8 al 10% del volumen total del líquido por pozo.
4. Dado que el ensayo CCK8 se basa en la actividad de deshidrogenasa en células vivas, las condiciones o productos químicos que afectan la actividad de deshidrogenasa pueden resultar en una diferencia entre el número real de células viables y el número de células viables medidas utilizando CCK8.
5. El WST-8 puede reaccionar con un agente reductor para formar WST-8 formazán. Si se utiliza un agente reductor (como algunos antioxidantes), interferirá con la prueba. Si hay más agente reductor presente en el sistema a probar, es necesario eliminarlo.
6. Después de 2 horas de incubación, el valor de O.D. de fondo suele ser de 0.1-0.2 unidades.
7. Tener cuidado de no introducir burbujas de aire en los pozos, ya que interferirán con el valor de O.D.
8. Si se desea esterilizar la solución CCK8, utilizar una solución filtrada con membrana de 0.2 μm.
9. El tiempo de incubación variará dependiendo del tipo y la cantidad de células en el pozo. Generalmente, los leucocitos son menos coloreados y pueden requerir tiempos de incubación más largos (hasta 4 horas) o grandes cantidades de células (~10^5 células/pozo).
10. Si hay alta turbidez en la suspensión celular, medir y restar el valor de O.D. de la muestra a 600 nm o más.
11. El CCK8 no se puede utilizar para la tinción de células.
12. El rojo de fenol en el medio no afecta los resultados experimentales. La absorbancia del rojo de fenol se puede eliminar restando la absorbancia del fondo en el pozo en blanco durante el cálculo, por lo que no afectará la detección.
13. La toxicidad del CCK8 es muy baja. Después de completar el ensayo CCK8, las mismas células se pueden utilizar para otros ensayos de proliferación celular, como el ensayo de violeta cristal, el ensayo de rojo neutro o el ensayo de fluorescencia de ADN. (A menos que las células sean extremadamente raras, no se recomienda).
14. Este kit se puede utilizar en E. coli pero no en células de levadura.
15. Antes de leer la placa, se puede mezclar suavemente en el agitador.
16. Se recomienda la inoculación de células en los pozos cercanos al centro de la placa. El medio en el círculo más externo de los pozos se evapora fácilmente y se puede llenar con PBS, agua o medio.
17. Si no se dispone de un filtro de 450 nm. También se pueden utilizar filtros con absorbancia entre 430 y 490 nm, y filtros de 450 nm para una sensibilidad óptima.
18. Medir la absorbancia a 450 nm. Si se necesita realizar una medición de longitud de onda dual, la absorbancia a 650 nm se puede determinar como longitud de onda de referencia.
19. La presencia de iones metálicos en el fármaco puede afectar la sensibilidad del CCK8. El cloruro de plomo, el cloruro de hierro y el sulfato de cobre a una concentración final de 1 mM inhiben el 5%, 15% y 90% de la reacción de color, reduciendo la sensibilidad. Si la concentración final es de 10 mM, será inhibida al 100%.
Applications |
1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
Shipping | Ship with blue ice. |
Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
Usage | For research use only! Not for use on humans. |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.
Average Rating: 5
(Based on Reviews and 420 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *